ProQR Therapeutics NV (PRQR)
1.405
-0.06
(-4.42%)
USD |
NASDAQ |
Jun 10, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Profit Margin (Quarterly) : -658.3% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -658.3% |
| December 31, 2025 | -190.3% |
| September 30, 2025 | -381.9% |
| June 30, 2025 | -319.1% |
| March 31, 2025 | -223.0% |
| December 31, 2024 | -216.0% |
| September 30, 2024 | -211.0% |
| June 30, 2024 | -42.70% |
| March 31, 2024 | -172.1% |
| December 31, 2023 | -167.0% |
| Date | Value |
|---|---|
| September 30, 2023 | -395.6% |
| June 30, 2023 | -662.0% |
| March 31, 2023 | -1.35K% |
| December 31, 2022 | -1.85K% |
| September 30, 2022 | -2.86K% |
| June 30, 2022 | -1.43K% |
| March 31, 2022 | -1.17K% |
| December 31, 2021 | -7.63K% |
| September 30, 2021 | -1.73K% |
| June 30, 2021 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pharming Group NV | -7.20% |
| NewAmsterdam Pharma Co. NV | -1.59K% |
| Kamada Ltd. | 9.13% |
| Syndax Pharmaceuticals, Inc. | -65.79% |
| Opus Genetics, Inc. | -3.04K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.31% |
| Return on Assets | -36.71% |
| Return on Invested Capital | -63.42% |
| Gross Profit Margin (Quarterly) | 65.86% |
| Operating Margin (Quarterly) | -671.4% |
| Return on Net Operating Assets | -282.6% |